Herantis Pharma’s financial year is the calendar year. During the year, the company publishes an Annual Financial Statements Release and one Interim Report related to accounting period’s first six months. The Financial Statements and Interim Reports will be released around at 9.00 a.m. (Finnish time) on the given dates.

Upcoming events

Date Event
4-5 Oct 2018 Herantis Pharma presentation at the 18th Annual Biotech in Europe Forum in Basel
4 Oct 2018 Patient seminar "Kohti Parkinsonin tautia hidastavaa hoitoa" in Helsinki
5-7 Nov 2018 Meet Herantis Pharma at BioEurope in Copenhagen
During the Silent period, the Company will not comment on its financial position, markets or outlooks. During the Silent period, the management will neither meet with capital market or financial media representatives, nor take a stand on matters concerning the Company’s financial position or general outlooks.
During the Closed window period, trading of Herantis Pharma shares or derivatives is forbidden for the Insider group.